ARTICLE | Clinical News
Immunomedics regulatory update
May 13, 1996 7:00 AM UTC
IMMU received U.S. Patent No. 5,514,363 covering methods for labeling proteins, particularly antibody fragments, with technetium and rhenium isotopes. IMMU incorporates technetium labeling in all of i...